ROCKWELL MEDICAL, INC. Debt Securities, Available-for-sale, Amortized Cost, Current
ROCKWELL MEDICAL, INC. (RMTI) had Debt Securities, Available-for-sale, Amortized Cost, Current of $9.14 million as of 2021-12-31, per its 10-Q filed 2022-08-15.
Discontinued › Notes › Debt Securities, Available-for-Sale, Amortized Cost
us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostCurrent · last filed 2022-08-15
- 2021-12-31: Debt Securities, Available-for-sale, Amortized Cost, Current $9.14M.
- 2021-09-30: Debt Securities, Available-for-sale, Amortized Cost, Current $9.80M.
- 2021-06-30: Debt Securities, Available-for-sale, Amortized Cost, Current $8.56M.
- 2021-03-31: Debt Securities, Available-for-sale, Amortized Cost, Current $10.44M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost, Current | Debt Securities, Available-for-sale, Amortized Cost, Current as first filed |
|---|---|---|
| 2021-12-31 | $9.14M 10-Q · filed 2022-08-15 | |
| 2021-09-30 | $9.80M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $8.56M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $10.44M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $9.99M 10-Q · filed 2021-11-15 | |
| 2020-09-30 | $10.68M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $13.17M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $11.39M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $14.24M 10-Q · filed 2020-11-09 | $14.24M 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |